المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/journal_contribution/PRISMA-IPD_Checklist_/16583189

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.s001

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/journal_contribution/Supporting_information_Methods_and_Results_/16583195

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.s002

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Malaria_reporting_form_/14613649

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s005

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Qualitative_interview_guide_/14613658

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s007

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Test_procedure_for_training_purposes_/14613637

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s002

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Training_slides_/14613634

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s001

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/G6PD_result_cards_for_patients_/14613652

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s006

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Test_procedure_folder_/14613640

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s003

المؤلفون: Jose Diego Brito-Sousa (8683908), Felipe Murta (6917279), Sheila Vitor-Silva (326120), Vanderson S. Sampaio (10094059), Maxwell O. Mendes (10819051), Marcelo A. M. Brito (10819054), Talita S. B. Batista (10819057), Alicia P. C. Santos (10819060), Leonardo L. G. Marques (10819063), Laila R. A. Barbosa (10819066), Marly M. Melo (10819069), Djane C. Baia-da-Silva (7339706), Alexandre V. Silva-Neto (10819072), Thalie C. Santos (10819075), Brenda K. A. Souza (10819078), Erick F. G. Figueiredo (3909619), Emanuelle L. Silva (10819081), Sheila Rodovalho (10819084), Theresa H. Nakagawa (10819087), Ana Ruth Arcanjo (10819090), André M. Siqueira (8537580), Gisely C. Melo (10819093), Judith Recht (3750991), Gonzalo J. Domingo (8842955), Quique Bassat (89288), Germana Bancone (34875), Wuelton M. Monteiro (7339718), Marcus V. G. Lacerda (7274882)

مصطلحات موضوعية: Medicine, Neuroscience, Biotechnology, Infectious Diseases, CareStart G 6PD screening test, Plasmodium vivax malaria, CareStart G 6PD test, Rio Preto da Eva, HCP, G 6PD test, G 6PD deficiency screening, training health care professionals, G 6PD, 12 malaria treatment units, G 6PD testing, Background Glucose -6-phosphate deh., 8- aminoquinolines-associated hemolysis, G 6PD deficiency, SAFEPRIM, 4- hour training session, MTU, January 2020. Training materials

Relation: https://figshare.com/articles/journal_contribution/Test_procedure_wall_poster_/14613643

الاتاحة: https://doi.org/10.1371/journal.pntd.0009415.s004

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Change_in_corrected_QT_interval_after_antimalarial_treatment_for_uncomplicated_malaria_/16583216

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g003

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Corrected_QT_interval_and_RR_interval_relationships_by_correction_method_and_individual_study_/16583207

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g002

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Study_selection_flowchart_/16583201

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g001

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Change_in_heart_rate_after_antimalarial_treatment_for_uncomplicated_malaria_in_individuals_aged_12_years_/16583228

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g005

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Differences_in_corrected_QT_interval_by_age_group_and_sex_/16583222

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g004

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/dataset/Multivariable_linear_mixed_effects_analysis_of_heart_rate_after_antimalarial_treatment_in_adolescents_and_adults_age_12_years_/16583261

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.t004

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/figure/Change_in_heart_rate_after_antimalarial_treatment_for_uncomplicated_malaria_in_individuals_aged_12_years_/16583234

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.g006

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/dataset/Characteristics_of_included_studies_/16583240

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.t001

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/dataset/Baseline_characteristics_of_included_population_in_ECG_interval_analysis_/16583246

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.t002

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/dataset/Multivariable_linear_mixed_effects_analysis_of_QT_interval_with_study-specific_correction_/16583255

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.t003

المؤلفون: Xin Hui S. Chan (8537544), Ilsa L. Haeusler (8537550), Yan Naung Win (8537547), James Pike (5169758), Borimas Hanboonkunupakarn (571549), Maryam Hanafiah (11402636), Sue J. Lee (8893442), Abdoulaye Djimdé (3504239), Caterina I. Fanello (11402639), Jean-René Kiechel (7539401), Marcus VG Lacerda (11269322), Bernhards Ogutu (683944), Marie A. Onyamboko (11402642), André M. Siqueira (8537580), Elizabeth A. Ashley (8537562), Walter RJ Taylor (11402645), Nicholas J. White (35779)

مصطلحات موضوعية: Medicine, Evolutionary Biology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, world health organization, torsade de pointes, thereby support development, compared within studies, based combination therapies, aminoquinoline antimalarial similar, although transient effects, +studies%22">xlink "> studies, risk minimisation measures, study limitations include, structurally related antimalarials, containing amodiaquine (<, +amodiaquine%22">xlink "> amodiaquine, bpm ], pyronaridine (− 1, amodiaquine prolonged qtcs, 8 %, 12 years compared, 0 %, 0013 ), lumefantrine, 001 ), pyronaridine

Time: 95

Relation: https://figshare.com/articles/dataset/Multivariable_linear_mixed_effects_analysis_of_heart_rate_after_antimalarial_treatment_in_children_age_12_years_/16583267

الاتاحة: https://doi.org/10.1371/journal.pmed.1003766.t005